01Perspective Therapeutics reported Q2 2026 earnings per share of -$0.22, beating the consensus estimate of -$0.27 by $0.05 per share on August 10, 2026.
02Revenue came in at $81.0K, missing analyst estimates of $114.0K, indicating a significant shortfall on the top line despite the EPS beat.
03The company's stock trades at $3.13 with a market capitalization of $200.3M, and has beaten EPS estimates in two consecutive quarters (Q2 and Q1 2026) but missed significantly in Q4 2025.
04The 18.5% EPS beat in Q2 represents a notable deviation from consensus that could trigger analyst estimate revisions, though the revenue miss suggests underlying business challenges.
Earnings Results
Perspective Therapeutics (AMEX:CATX) reported quarterly earnings results on August 10, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $-0.22, beating the consensus estimate of $-0.27 by $0.05 per share. Revenue came in at $81.0K, missing the estimate of $114.0K.
Company Overview
Perspective Therapeutics's stock moved following the earnings release. The stock currently trades at $3.13 with a market capitalization of $200.3M.
Perspective Therapeutics's earnings outperformance reflects execution that exceeded Wall Street's expectations. Earnings beats can lead to upward estimate revisions from analysts, which often correlate with sustained stock price appreciation over the following weeks as models are updated.
The 19% beat relative to consensus estimates is a notable deviation. Earnings surprises of this magnitude often trigger analyst revisions and can influence institutional positioning in the weeks following the report.
Earnings reports are most useful when viewed as part of a trend rather than in isolation. Investors tracking Perspective Therapeutics should compare this quarter's results against both year-over-year figures and sequential performance to identify whether the business is accelerating, stabilizing, or decelerating. The earnings calendar on Smart Investors Daily tracks upcoming report dates across all publicly traded companies.